Thermo Fisher Scientific
TMO
873 hedge funds and large institutions have $40.1B invested in Thermo Fisher Scientific in 2013 Q4 according to their latest regulatory filings, with 114 funds opening new positions, 253 increasing their positions, 380 reducing their positions, and 53 closing their positions.
115% more first-time investments, than exits
New positions opened: 114 | Existing positions closed: 53
27% more funds holding in top 10
Funds holding in top 10: 66 → 84 (+18)
22% more capital invested
Capital invested by funds: $32.9B → $40.1B (+$7.22B)
7% more funds holding
Funds holding: 817 → 873 (+56)
4% more call options, than puts
Call options by funds: $342M | Put options by funds: $328M
0.75% more ownership
Funds ownership: 98.9% → 99.65% (+0.75%)
33% less repeat investments, than reductions
Existing positions increased: 253 | Existing positions reduced: 380
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$148M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$141M |
| 3 |
CG
Carmignac Gestion
Paris,
France
|
+$138M |
| 4 |
Capital Research Global Investors
Los Angeles,
California
|
+$112M |
| 5 |
ECP
Empyrean Capital Partners
Los Angeles,
California
|
+$77.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$174M |
| 2 |
TP
Third Point
New York
|
-$143M |
| 3 |
PC
Paulson & Co
New York
|
-$101M |
| 4 |
Bank of New York Mellon
New York
|
-$91.5M |
| 5 |
Charles Schwab
San Francisco,
California
|
-$67.9M |
TMO Hedge Fund Activity: Q4 2013 in Review
873 of the 3,459 institutional investors tracked by Wall St. Rank reported a position in Thermo Fisher Scientific (TMO) for Q4 2013, worth a combined $40.1B — up 22% from $32.9B a quarter earlier.
Buyers outnumbered sellers: 114 funds opened new TMO positions and 53 closed out — a net gain of 61 holders — while 253 added to existing stakes and 380 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $148M. The largest seller was PFM Health Sciences, cutting an estimated $174M.
- 873 institutional investors held Thermo Fisher Scientific (TMO) as of Q4 2013, up from 817 in Q3 2013.
- Funds reported $40.1B of Thermo Fisher Scientific stock for Q4 2013, up 22% quarter-over-quarter.
- 114 funds opened new Thermo Fisher Scientific positions in Q4 2013 and 53 closed out, a net change of +61 holders.
- The largest Thermo Fisher Scientific buyer in Q4 2013 was Fidelity Investments, an estimated $148M added.
- The largest Thermo Fisher Scientific seller in Q4 2013 was PFM Health Sciences, an estimated $174M sold.
Based on aggregated 13F filings for Q4 2013.